title: [Pulmonary hypertension].
authors.affiliation: Medizinische Klinik und Poliklinik II, Universitätsklinikum Giessen. Horst.Olschewski@innere.med.uni-giessen.de
authors.forename: H
authors.initials: H
authors.lastname: Olschewski
authors.forename: A
authors.initials: A
authors.lastname: Ghofrani
authors.forename: R
authors.initials: R
authors.lastname: Wiedemann
authors.forename: F
authors.initials: F
authors.lastname: Rose
authors.forename: B
authors.initials: B
authors.lastname: Enke
authors.forename: T
authors.initials: T
authors.lastname: Gessler
authors.forename: R
authors.initials: R
authors.lastname: Voswinckel
authors.forename: M
authors.initials: M
authors.lastname: Kohstall
authors.forename: F
authors.initials: F
authors.lastname: Grimminger
authors.forename: W
authors.initials: W
authors.lastname: Seeger
mesh_terms: D000959:Antihypertensive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002121:Calcium Channel Blockers / Q000009:adverse effects / Q000627:therapeutic use; D065128:Endothelin Receptor Antagonists; D011464:Epoprostenol / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use; D006801:Humans; D006976:Hypertension, Pulmonary / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D014665:Vasodilator Agents / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D000959:Antihypertensive Agents; D002121:Calcium Channel Blockers; D065128:Endothelin Receptor Antagonists; D014665:Vasodilator Agents; D011464:Epoprostenol